Clinical Translation of Cancer Nanotechnology
J. Donald Payne
President and CEO, Director Nanospectra Bioscience, Inc
Mr. Payne has been the CEO from the commencement of operations in 2002. He has 30 years of progressively senior management experience including prior executive roles at Life Cell, Sensus Drug Development, and Aprogenex. He holds an MBA from Rice University and a BBA from Texas A&M.
Speaking in the symposiums on Nanotechnology for Cancer Prevention, Diagnosis and Treatment, Nano Medicine and Drug Delivery